Published in Prim Care Respir J on August 01, 2007
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res (2013) 1.06
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet (2009) 1.06
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol (2009) 1.05
The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. Caspian J Intern Med (2012) 1.04
Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir Res (2013) 1.03
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 0.96
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study. BMC Pulm Med (2010) 0.84
Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulm Med (2009) 0.83
Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients. Multidiscip Respir Med (2010) 0.81
Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients. Tanaffos (2015) 0.81
The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.80
Variability in proteinase-antiproteinase balance, nutritional status, and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology. Lung India (2016) 0.79
Functional Status Assessment of COPD Based on Ability to Perform Daily Living Activities: A Systematic Review of Paper and Pencil Instruments. Glob J Health Sci (2015) 0.79
Genetics of asthma susceptibility and severity. Clin Chest Med (2012) 0.78
External quality control for dried blood spot-based C-reactive protein assay: experience from the indonesia family life survey and the longitudinal aging study in India. Biodemography Soc Biol (2015) 0.77
Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting. J Immunol Res (2015) 0.75
Different forms of adiponectin reduce the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells. Exp Ther Med (2016) 0.75
Assessing upper-extremity motion: An innovative method to quantify functional capacity in patients with chronic obstructive pulmonary disease. PLoS One (2017) 0.75
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med (2007) 8.06
WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care. World Psychiatry (2010) 3.54
Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am Coll Cardiol (2007) 2.56
Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis (2008) 1.76
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am J Transplant (2004) 1.69
Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol (2008) 1.38
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. Transplantation (2002) 1.33
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. Transplantation (2005) 1.24
Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol (2005) 1.23
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation (2004) 1.14
Up-beat UK: a programme of research into the relationship between coronary heart disease and depression in primary care patients. BMC Fam Pract (2011) 1.05
Mass media interventions for reducing mental health-related stigma. Cochrane Database Syst Rev (2013) 1.02
Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology. COPD (2007) 0.95
A pilot randomised controlled trial of personalised care for depressed patients with symptomatic coronary heart disease in South London general practices: the UPBEAT-UK RCT protocol and recruitment. BMC Psychiatry (2012) 0.90
Caffeine for asthma. Cochrane Database Syst Rev (2010) 0.89
Self efficacy measurement and goal attainment after pulmonary rehabilitation. Int J Chron Obstruct Pulmon Dis (2008) 0.84
A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011. Int J Chron Obstruct Pulmon Dis (2013) 0.83
Pregnancy-associated plasma protein A: Has this biomarker crossed the boundary from research to clinical practice? Drug News Perspect (2009) 0.83
User-held personalised information for routine care of people with severe mental illness. Cochrane Database Syst Rev (2013) 0.81
A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients. Br J Clin Pharmacol (2013) 0.81
Building mental health workforce capacity through training and retention of psychiatrists in Zimbabwe. Int Rev Psychiatry (2014) 0.80
Biochemical and psychometric evaluation of Self-Healing Qigong as a stress reduction tool among first year nursing and midwifery students. Complement Ther Clin Pract (2013) 0.78
Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation. Int J Chron Obstruct Pulmon Dis (2007) 0.78
Comment on immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem (2006) 0.77
Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity. Am Heart J (2003) 0.76
Mechanism of statin-associated mortality reduction in COPD. Chest (2007) 0.75
Comment on: HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005; 33(11):1309-1319. Exp Hematol (2006) 0.75
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation? Expert Opin Pharmacother (2005) 0.75
CYP3A5 genotype does not influence the blood concentration of tacrolimus measured with the Abbott immunoassay. Clin Chem (2005) 0.75